JP2005538109A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538109A5
JP2005538109A5 JP2004524924A JP2004524924A JP2005538109A5 JP 2005538109 A5 JP2005538109 A5 JP 2005538109A5 JP 2004524924 A JP2004524924 A JP 2004524924A JP 2004524924 A JP2004524924 A JP 2004524924A JP 2005538109 A5 JP2005538109 A5 JP 2005538109A5
Authority
JP
Japan
Prior art keywords
inhibitor
compound
pharmaceutical composition
compound according
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004524924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538109A (ja
JP4505327B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/023499 external-priority patent/WO2004010992A1/en
Publication of JP2005538109A publication Critical patent/JP2005538109A/ja
Publication of JP2005538109A5 publication Critical patent/JP2005538109A5/ja
Application granted granted Critical
Publication of JP4505327B2 publication Critical patent/JP4505327B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004524924A 2002-07-30 2003-07-25 異常脂血症および他の脂質障害の治療用のPPARα選択的化合物 Expired - Fee Related JP4505327B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39951802P 2002-07-30 2002-07-30
PCT/US2003/023499 WO2004010992A1 (en) 2002-07-30 2003-07-25 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

Publications (3)

Publication Number Publication Date
JP2005538109A JP2005538109A (ja) 2005-12-15
JP2005538109A5 true JP2005538109A5 (cg-RX-API-DMAC7.html) 2006-09-07
JP4505327B2 JP4505327B2 (ja) 2010-07-21

Family

ID=31188591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004524924A Expired - Fee Related JP4505327B2 (ja) 2002-07-30 2003-07-25 異常脂血症および他の脂質障害の治療用のPPARα選択的化合物

Country Status (8)

Country Link
US (1) US7297715B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539137B1 (cg-RX-API-DMAC7.html)
JP (1) JP4505327B2 (cg-RX-API-DMAC7.html)
AT (1) ATE468851T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003256911B2 (cg-RX-API-DMAC7.html)
CA (1) CA2493913A1 (cg-RX-API-DMAC7.html)
DE (1) DE60332738D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004010992A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050532A (sr) 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
AU2004231106A1 (en) * 2003-04-14 2004-10-28 The Institutes For Pharmaceutical Discovery, Llc N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
EA200501710A1 (ru) 2003-04-30 2006-06-30 ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи Замещённые карбоновые кислоты
KR20060056944A (ko) 2003-07-14 2006-05-25 아레나 파마슈티칼스, 인크. 대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
WO2005024057A1 (en) * 2003-09-10 2005-03-17 Galapagos Genomics N.V. Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
EP1566202A1 (en) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Use of resistin antagonists in the treatment of rheumatoid arthritis
MX2007001634A (es) 2004-08-11 2007-04-23 Kyorin Seiyaku Kk Nuevo derivado de acido amino benzoico ciclico.
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US20090036489A1 (en) * 2005-03-22 2009-02-05 Masahiro Nomura Novel Cyclic Aminophenylalkanoic Acid Derivative
WO2008091338A1 (en) * 2007-01-23 2008-07-31 Reddy Us Therapeutics, Inc. Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipidemia
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
WO2008128126A1 (en) 2007-04-11 2008-10-23 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US8142826B2 (en) * 2007-11-05 2012-03-27 Naturex, Inc. Extract of Fraxinus excelsior seeds and therapeutic applications therefor
US8883721B2 (en) * 2009-05-12 2014-11-11 Mcgill University Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
WO2011159917A2 (en) 2010-06-16 2011-12-22 The Administrators Of The Tulane Educational Fund Growth hormone secretatogue receptor antagonists and uses thereof
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ, インコーポレイテッド S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
KR101934197B1 (ko) * 2017-06-12 2018-12-31 아주대학교산학협력단 PPARα/γ 이중 작용 활성을 갖는 신규 화합물 및 이를 유효성분으로 함유하는 대사질환 예방 또는 치료용 조성물
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US5273999A (en) * 1991-09-10 1993-12-28 Hoffmann-La Roche Inc. Carboxylic acid leukotriene B4 antagonists
NZ515087A (en) * 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
FR2802808B1 (fr) * 1999-12-22 2002-08-09 Oreal Utilisation de composes polycycliques aromatiques en tant qu'activateurs des recepteurs de type ppars dans une composition cosmetique ou pharmaceutique
JP2004513090A (ja) * 2000-09-27 2004-04-30 メルク エンド カムパニー インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
JP2002114781A (ja) * 2000-10-06 2002-04-16 Sankyo Co Ltd 置換縮合イミダゾール誘導体を含有する糖尿病の予防剤、治療剤

Similar Documents

Publication Publication Date Title
CA2510540A1 (en) Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
CA2488592A1 (en) 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
US7041837B2 (en) Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine
JP2006500384A5 (cg-RX-API-DMAC7.html)
JP5786034B2 (ja) 脂質異常症の治療に適したヘテロ環式化合物
CA2525764A1 (en) N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
JP2005511634A5 (cg-RX-API-DMAC7.html)
HRP20241674T1 (hr) 6'-[[(1s,3s)-3-[[5-(difluormetoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i postupci njegove upotrebe
CA2463154A1 (en) Heterocyclic compounds and methods of use
JP2022116083A5 (cg-RX-API-DMAC7.html)
JP2004513076A5 (cg-RX-API-DMAC7.html)
US9572798B2 (en) Therapeutic agent for dyslipidemia
JP2016500063A5 (cg-RX-API-DMAC7.html)
JP2011528362A5 (cg-RX-API-DMAC7.html)
HRP20120476T1 (hr) Derivati 4-benzilamino-1-karboksiacil-piperidina kao cetp inhibitori korisni za liječenje bolesti kao što su hiperlipidemija ili arterioskleroza
JP2008513516A5 (cg-RX-API-DMAC7.html)
JP2010529203A5 (cg-RX-API-DMAC7.html)
CN1898202A (zh) 抗高胆固醇血症化合物
WO2008035359A2 (en) Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
WO2007099553A2 (en) 1,3-dioxane carboxylic acids
US9273041B2 (en) Compounds for the treatment of dyslipidemia and related diseases
JP2016521279A5 (cg-RX-API-DMAC7.html)
JP2007527433A5 (cg-RX-API-DMAC7.html)
US20150051144A1 (en) Compounds for the treatment of dyslipidemia and other diseases
CA2598725A1 (en) Fused aromatic compounds having anti-diabetic activity